(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of -3.71% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Masimo's revenue in 2025 is $1,973,600,000.On average, 5 Wall Street analysts forecast MASI's revenue for 2025 to be $82,338,776,131, with the lowest MASI revenue forecast at $82,141,960,740, and the highest MASI revenue forecast at $82,718,309,943. On average, 5 Wall Street analysts forecast MASI's revenue for 2026 to be $88,647,712,469, with the lowest MASI revenue forecast at $88,279,564,671, and the highest MASI revenue forecast at $89,369,368,903.
In 2027, MASI is forecast to generate $95,694,570,975 in revenue, with the lowest revenue forecast at $95,203,345,784 and the highest revenue forecast at $96,803,894,089.